IL6 and cancer: In addition to alterations in adiponectin and leptin levels, elevated levels of other adipokines, such as resistin, interleukin‐6 (IL‐6), and tumor necrosis factor‐alpha (TNF‐α), are associated with an increased risk of cancer [53].